1amb: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1amb.gif|left|200px]] | [[Image:1amb.gif|left|200px]] | ||
'''SOLUTION STRUCTURE OF RESIDUES 1-28 OF THE AMYLOID BETA-PEPTIDE''' | {{Structure | ||
|PDB= 1amb |SIZE=350|CAPTION= <scene name='initialview01'>1amb</scene> | |||
|SITE= | |||
|LIGAND= | |||
|ACTIVITY= | |||
|GENE= | |||
}} | |||
'''SOLUTION STRUCTURE OF RESIDUES 1-28 OF THE AMYLOID BETA-PEPTIDE''' | |||
==Overview== | ==Overview== | ||
| Line 10: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
1AMB is a [ | 1AMB is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1AMB OCA]. | ||
==Reference== | ==Reference== | ||
Solution structure of residues 1-28 of the amyloid beta-peptide., Talafous J, Marcinowski KJ, Klopman G, Zagorski MG, Biochemistry. 1994 Jun 28;33(25):7788-96. PMID:[http:// | Solution structure of residues 1-28 of the amyloid beta-peptide., Talafous J, Marcinowski KJ, Klopman G, Zagorski MG, Biochemistry. 1994 Jun 28;33(25):7788-96. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/7516706 7516706] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
| Line 22: | Line 31: | ||
[[Category: proteinase inhibitor(trypsin)]] | [[Category: proteinase inhibitor(trypsin)]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 09:59:27 2008'' | ||
Revision as of 10:59, 20 March 2008
| |||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
SOLUTION STRUCTURE OF RESIDUES 1-28 OF THE AMYLOID BETA-PEPTIDE
OverviewOverview
The three-dimensional solution structure of residues 1-28 of the amyloid beta-peptide was determined using nuclear magnetic resonance spectroscopy, distance geometry, and molecular dynamic techniques. The nuclear magnetic resonance data used to derive the structure consisted of nuclear Overhauser enhancements, vicinal coupling constants, and temperature coefficients of the amide-NH chemical shifts. The beta-peptide is the major proteinaceous component of amyloid deposits in Alzheimer's disease. In membrane-like media, the peptide folds to form a predominately alpha-helical structure with a bend centered at residue 12. The side chains of histidine-13 and lysine-16 are close, residing on the same face of the helix. Their proximity may constitute a binding motif with the heparan sulfate proteoglycans. The molecular details of the structure shown here could facilitate the design of rational treatments to curtail the binding of heparan sulfate proteoglycans or to prevent an alpha-helix-->beta-sheet conversion that may occur during the early stages of amyloid formation in Alzheimer's disease.
DiseaseDisease
Known diseases associated with this structure: Alzheimer disease-1, APP-related OMIM:[104760], Amyloidosis, cerebroarterial, Dutch type OMIM:[104760], Amyloidosis, cerebroarterial, Iowa type OMIM:[104760], Blood group, P system OMIM:[607922]
About this StructureAbout this Structure
1AMB is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
Solution structure of residues 1-28 of the amyloid beta-peptide., Talafous J, Marcinowski KJ, Klopman G, Zagorski MG, Biochemistry. 1994 Jun 28;33(25):7788-96. PMID:7516706
Page seeded by OCA on Thu Mar 20 09:59:27 2008